In some tumors (e.g., GBM, NSCLC), the percentage of NKG2A+ Vδ2 T cells can exceed that of those circulating in the blood, although it is not clear whether this higher expression level is induced by the TME or whether it is due to the preferable infiltration of this subset to the tumor side. This evidence concerns the gene KLRC1 and glioblastoma.